Atlas Trials

Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation

Clinical trial NCT02564354 · COMPLETED

Trial details

NCT number
NCT02564354
Sponsor
ProQR Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2015-09-01
Primary completion
2016-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.